HC Wainwright Issues Pessimistic Outlook for Geron Earnings
Geron Co. (NASDAQ:GERN – Free Report) – Stock analysts at HC Wainwright decreased their Q1 2025 earnings estimates for shares of Geron in a research report issued to clients and investors on Wednesday, February 26th. HC Wainwright analyst E. Bodnar now forecasts that the biopharmaceutical company will post earnings of ($0.04) per share for the […]
